PFE: Pfizer Give Equities a Shot in the Arm

Unless you live under a rock, you know that Pfizer and their partner BioNTech announced the results of their Phase III trials for their SARS-CoV-2 vaccine. The company claims that the vaccine is 90% effective in stopping people from catching the Covid.

This article is for paid members - please login or subscribe for access.

Share: